Mabjeesh et al71 showed that detection of mRNA of PSA and hK2 transcripts by polymerase chain reaction (PCR) in the peripheral blood of patients with prostate cancer during brachytherapy can predict the biochemical outcome. The gene discussed is HK2; the disease is prostate carcinoma.